Health
DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2, Lead Candidates Described in Science Publication | Antibodies | News Channels – PipelineReview.com
La Merie Publishing prepares brief and full reports as well as competitor analysis reports, the latter in a tabulated format with structured listings of industry-relevant…
Details
Category: Antibodies
Published on Tuesday, 12 January 2021 16:21
Hits: 125
– Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike protein.
– Lead candidates DIOS-202 and DIOS-203 are engineered for high potency and their potential to avoid the emergence of escape mutants.
– DIOS-202 and DIOS-203 entered into accelerated development to initiate clinical studies later this year.
BONN, Germany I January 12,…
-
General12 hours agoAnne-Marie Te Whiu on new book of poetry, Mettle, and why she dedicated it to her younger self
-
Business6 hours agoGold price alert! Macquarie reveals its top ASX 200 gold stock as the metal hits all-time high
-
General22 hours agoKAP leader says he was unaware man next to him at rally was wearing neo-Nazi insignia
-
Noosa News13 hours agoJazz sellout at The J